Related news and resources
Open letter from the innovative pharmaceutical industry to G7 leaders
Ahead of the G7 Leaders’ Summit in Kananaskis from 15 to 17 2025, the global pharmaceutical industry, represented by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and Innovative Medicines Canada (IMC), are calling on G7 governments to place health and innovation at the top of their agenda.
Read morePharmaceutical industry calls on G7 to prioritize innovation as strategic pillar for health, growth, and security
Ahead of the G7 Leaders’ Summit, IFPMA and Innovative Medicines Canada (IMC) reaffirm the innovative pharmaceutical industry’s commitment to partnering with G7 governments to improve patient outcomes, strengthen health systems, boost economic growth, and support national security.
Read more
WHA78 individual statement on antimicrobial resistance (AMR)
On 27 May 2025, IFPMA delievered a statement at the 78th session of the World Health Assembly on antimicrobial resistance.
Read more